共 12 条
[2]
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
[J].
CLINICAL THERAPEUTICS,
2004, 26 (11)
:1758-1773
[7]
Knopp RH, 2003, INT J CLIN PRACT, V57, P363
[10]
Simard Chantale, 2003, Can J Clin Pharmacol, V10 Suppl A, p13A